APA (7th ed.) Citation

Break, T. J., Oikonomou, V., Dutzan, N., Desai, J. V., Swidergall, M., Freiwald, T., . . . Lionakis, M. S. (2021). Response to Comments on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections”. Science, 373, . https://doi.org/10.1126/science.abi8835

Chicago Style (17th ed.) Citation

Break, Timothy J., et al. "Response to Comments on “Aberrant Type 1 Immunity Drives Susceptibility to Mucosal Fungal Infections”." Science 373 (2021). https://doi.org/10.1126/science.abi8835.

MLA (9th ed.) Citation

Break, Timothy J., et al. "Response to Comments on “Aberrant Type 1 Immunity Drives Susceptibility to Mucosal Fungal Infections”." Science, vol. 373, 2021, https://doi.org/10.1126/science.abi8835.